A PHARMACOKINETIC STUDY OF MELPHALAN HCL FOR INJECTION (PROPYLENE GLYCOL-FREE) AND ALKERAN FOR INJECTION FOR MYELOABLATIVE CONDITIONING IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION: